Clinical Trial Update: Effects of Graptopetalum Paraguayense E. Walther on the Oxidative Stress, Antioxidant Enzyme Activity and Inflammation in Subjects With Metabolic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on Phase 2 and Phase 3 study assessing Graptopetalum paraguayense extract for its effects on oxidative stress, antioxidant enzyme activi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Graptopetalum paraguayense extract (Graptopetalum paraguayense extract)

Snippet

Sponsor: Chung Shan Medical University | Conditions: Metabolic Syndrome | Phase 2, Phase 3 | Status: COMPLETED